$CPHD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CEPHEID.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CEPHEID. Get notifications about new insider transactions in CEPHEID for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 16 17 ... 19 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 29 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,563 | 0 | 15,625 | |
Oct 29 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 31.10 | 730 | 22,703 | 27,616 | 28.3 K to 27.6 K (-2.58 %) |
Oct 29 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,563 | 0 | 28,346 | 26.8 K to 28.3 K (+5.84 %) |
Oct 29 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 250 | 0 | 2,500 | |
Oct 29 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 31.10 | 117 | 3,639 | 3,245 | 3.4 K to 3.2 K (-3.48 %) |
Oct 29 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 250 | 0 | 3,362 | 3.1 K to 3.4 K (+8.03 %) |
Oct 25 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 31.50 | 3,000 | 94,502 | 694,300 | 697.3 K to 694.3 K (-0.43 %) |
Oct 23 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 7.35 | 7,500 | 55,125 | 0 | |
Oct 23 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Sell | S | 31.63 | 7,500 | 237,192 | 76,860 | 84.4 K to 76.9 K (-8.89 %) |
Oct 23 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 7.35 | 7,500 | 55,125 | 84,360 | 76.9 K to 84.4 K (+9.76 %) |
Aug 30 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 37.41 | 40,000 | 1,496,564 | 700,300 | 740.3 K to 700.3 K (-5.40 %) |
Sep 25 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 40.13 | 3,000 | 120,404 | 697,300 | 700.3 K to 697.3 K (-0.43 %) |
Aug 30 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 14.93 | 15,000 | 223,950 | 115,000 | |
Aug 30 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Sell | S | 37.12 | 15,000 | 556,784 | 3,112 | 18.1 K to 3.1 K (-82.82 %) |
Aug 30 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 14.93 | 15,000 | 223,950 | 18,112 | 3.1 K to 18.1 K (+482.01 %) |
Aug 30 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Option Exercise | M | 5.20 | 7,500 | 39,000 | 0 | |
Aug 30 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Sell | S | 36.82 | 7,500 | 276,150 | 76,860 | 84.4 K to 76.9 K (-8.89 %) |
Aug 30 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Buy | M | 5.20 | 7,500 | 39,000 | 84,360 | 76.9 K to 84.4 K (+9.76 %) |
Aug 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 35.97 | 3,000 | 107,910 | 740,300 | 743.3 K to 740.3 K (-0.40 %) |
Jul 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 270 | 0 | 1,896 | |
Jul 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 32.93 | 127 | 4,182 | 2,126 | 2.3 K to 2.1 K (-5.64 %) |
Jul 31 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 270 | 0 | 2,253 | 2 K to 2.3 K (+13.62 %) |
Aug 13 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 37.83 | 390 | 14,754 | 76,860 | 76.5 K to 76.9 K (+0.51 %) |
Aug 13 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 37.83 | 375 | 14,186 | 1,916 | 1.5 K to 1.9 K (+24.33 %) |
Aug 13 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 37.83 | 506 | 19,142 | 19,706 | 19.2 K to 19.7 K (+2.64 %) |
Aug 13 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 37.83 | 546 | 20,655 | 183,453 | 182.9 K to 183.5 K (+0.30 %) |
Jul 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 312 | 0 | 2,188 | |
Jul 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 32.93 | 146 | 4,808 | 6,771 | 6.9 K to 6.8 K (-2.11 %) |
Jul 31 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 312 | 0 | 6,917 | 6.6 K to 6.9 K (+4.72 %) |
Jul 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 338 | 0 | 2,370 | |
Jul 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 32.93 | 158 | 5,203 | 14,033 | 14.2 K to 14 K (-1.11 %) |
Jul 31 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 338 | 0 | 14,191 | 13.9 K to 14.2 K (+2.44 %) |
Jul 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 2,370 | |
Jul 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 32.93 | 158 | 5,203 | 2,578 | 2.7 K to 2.6 K (-5.77 %) |
Jul 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 2,736 | 2.4 K to 2.7 K (+14.10 %) |
Jul 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 8,750 | |
Jul 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 32.93 | 584 | 19,231 | 7,221 | 7.8 K to 7.2 K (-7.48 %) |
Jul 31 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 7,805 | 6.6 K to 7.8 K (+19.07 %) |
Jul 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 8,750 | |
Jul 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 32.93 | 584 | 19,231 | 26,678 | 27.3 K to 26.7 K (-2.14 %) |
Jul 31 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 27,262 | 26 K to 27.3 K (+4.81 %) |
Jul 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 343 | 0 | 2,407 | |
Jul 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 32.93 | 161 | 5,302 | 2,534 | 2.7 K to 2.5 K (-5.97 %) |
Jul 31 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 343 | 0 | 2,695 | 2.4 K to 2.7 K (+14.58 %) |
Jul 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 250 | 0 | 2,750 | |
Jul 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 32.51 | 117 | 3,804 | 6,605 | 6.7 K to 6.6 K (-1.74 %) |
Jul 26 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 250 | 0 | 6,722 | 6.5 K to 6.7 K (+3.86 %) |
Jul 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 312 | 0 | 3,438 | |
Jul 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 32.51 | 146 | 4,746 | 13,853 | 14 K to 13.9 K (-1.04 %) |
Jul 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 312 | 0 | 13,999 | 13.7 K to 14 K (+2.28 %) |
Jul 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 3,322 | |
Jul 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 32.51 | 141 | 4,584 | 2,398 | 2.5 K to 2.4 K (-5.55 %) |
Jul 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 2,539 | 2.2 K to 2.5 K (+13.50 %) |
Jul 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 250 | 0 | 2,750 | |
Jul 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 32.51 | 117 | 3,804 | 6,555 | 6.7 K to 6.6 K (-1.75 %) |
Jul 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 250 | 0 | 6,672 | 6.4 K to 6.7 K (+3.89 %) |
Jul 26 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 250 | 0 | 2,750 | |
Jul 26 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 32.51 | 92 | 2,991 | 1,983 | 2.1 K to 2 K (-4.43 %) |
Jul 26 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 250 | 0 | 2,075 | 1.8 K to 2.1 K (+13.70 %) |
Jul 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,562 | 0 | 17,188 | |
Jul 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 32.51 | 730 | 23,732 | 26,012 | 26.7 K to 26 K (-2.73 %) |
Jul 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,562 | 0 | 26,742 | 25.2 K to 26.7 K (+6.20 %) |
Jul 26 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 33.87 | 3,000 | 101,596 | 743,300 | 746.3 K to 743.3 K (-0.40 %) |
Jul 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 250 | 0 | 2,750 | |
Jul 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 32.51 | 117 | 3,804 | 2,352 | 2.5 K to 2.4 K (-4.74 %) |
Jul 26 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 250 | 0 | 2,469 | 2.2 K to 2.5 K (+11.27 %) |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 9.18 | 100 | 918 | 134,799 | |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 9.18 | 40,101 | 368,127 | 134,899 | |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 46.00 | 100 | 4,600 | 25,180 | 25.3 K to 25.2 K (-0.40 %) |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 9.18 | 100 | 918 | 25,280 | 25.2 K to 25.3 K (+0.40 %) |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 46.00 | 15,101 | 694,646 | 25,180 | 40.3 K to 25.2 K (-37.49 %) |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 45.50 | 25,000 | 1,137,500 | 40,281 | 65.3 K to 40.3 K (-38.30 %) |
Jul 03 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 9.18 | 40,101 | 368,127 | 65,281 | 25.2 K to 65.3 K (+159.26 %) |
Jul 03 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 9.11 | 9,600 | 87,456 | 38,400 | |
Jul 03 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 9,134 | 39,276 | 10 | |
Jul 03 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 46.00 | 9,600 | 441,600 | 6,472 | 16.1 K to 6.5 K (-59.73 %) |
Jul 03 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 45.50 | 9,134 | 415,597 | 16,072 | 25.2 K to 16.1 K (-36.24 %) |
Jul 03 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 9.11 | 9,600 | 87,456 | 25,206 | 15.6 K to 25.2 K (+61.51 %) |
Jul 03 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 9,134 | 39,276 | 15,606 | 6.5 K to 15.6 K (+141.13 %) |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 15,000 | |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 45.69 | 5,000 | 228,450 | 2,237 | 7.2 K to 2.2 K (-69.09 %) |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 45.23 | 5,000 | 226,150 | 7,237 | 12.2 K to 7.2 K (-40.86 %) |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 12,237 | 2.2 K to 12.2 K (+447.03 %) |
Jun 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 4.30 | 13,047 | 56,102 | 9,144 | |
Jun 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 45.00 | 8,800 | 396,000 | 6,472 | 15.3 K to 6.5 K (-57.62 %) |
Jun 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Sell | S | 44.50 | 4,247 | 188,992 | 15,272 | 19.5 K to 15.3 K (-21.76 %) |
Jun 28 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 4.30 | 13,047 | 56,102 | 19,519 | 6.5 K to 19.5 K (+201.59 %) |
Jun 28 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 9.18 | 25,000 | 229,500 | 175,000 | |
Jun 28 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Sell | S | 45.00 | 25,000 | 1,125,000 | 25,180 | 50.2 K to 25.2 K (-49.82 %) |
Jun 28 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 9.18 | 25,000 | 229,500 | 50,180 | 25.2 K to 50.2 K (+99.29 %) |
Jun 28 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 25,000 | |
Jun 28 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 44.79 | 5,000 | 223,950 | 2,237 | 7.2 K to 2.2 K (-69.09 %) |
Jun 28 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 7,237 | 2.2 K to 7.2 K (+223.51 %) |
May 29 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 37.99 | 3,000 | 113,984 | 749,300 | 752.3 K to 749.3 K (-0.40 %) |
Jun 27 2012 | CPHD | CEPHEID | GUTSHALL THOMAS L | Director | Sell | S | 42.66 | 3,000 | 127,971 | 746,300 | 749.3 K to 746.3 K (-0.40 %) |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 20.47 | 2,437 | 49,885 | 19,501 | |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 8.43 | 2,500 | 21,075 | 10,000 | |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 21.00 | 12,500 | 262,500 | 0 | |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 41.77 | 4,937 | 206,218 | 6,422 | 11.4 K to 6.4 K (-43.46 %) |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Sell | S | 41.43 | 12,500 | 517,875 | 11,359 | 23.9 K to 11.4 K (-52.39 %) |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 20.47 | 2,437 | 49,885 | 23,859 | 21.4 K to 23.9 K (+11.38 %) |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 8.43 | 2,500 | 21,075 | 21,422 | 18.9 K to 21.4 K (+13.21 %) |
Jun 21 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 21.00 | 12,500 | 262,500 | 18,922 | 6.4 K to 18.9 K (+194.64 %) |
May 21 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 37.49 | 324 | 12,147 | 1,541 | 1.2 K to 1.5 K (+26.62 %) |
May 21 2012 | CPHD | CEPHEID | STEELE GLENN JR MD PHD | Director | Grant | A | 37.49 | 324 | 12,147 | 1,541 | 1.2 K to 1.5 K (+26.62 %) |
May 21 2012 | CPHD | CEPHEID | KEPNER CRISTINA | Director | Grant | A | 37.49 | 473 | 17,733 | 182,907 | 182.4 K to 182.9 K (+0.26 %) |
May 21 2012 | CPHD | CEPHEID | EASTON ROBERT J | Director | Grant | A | 37.49 | 347 | 13,009 | 76,470 | 76.1 K to 76.5 K (+0.46 %) |
May 01 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Option Exercise | M | 0.00 | 313 | 0 | 2,500 | |
May 01 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Payment of Exercise | F | 38.50 | 147 | 5,660 | 6,472 | 6.6 K to 6.5 K (-2.22 %) |
May 01 2012 | CPHD | CEPHEID | SMITH JOSEPH H | SVP, Bus Dev and GC | Buy | M | 0.00 | 313 | 0 | 6,619 | 6.3 K to 6.6 K (+4.96 %) |
May 21 2012 | CPHD | CEPHEID | Brown Thomas D | Director | Grant | A | 37.49 | 441 | 16,533 | 19,200 | 18.8 K to 19.2 K (+2.35 %) |
May 01 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 339 | 0 | 2,708 | |
May 01 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 38.50 | 159 | 6,122 | 13,687 | 13.8 K to 13.7 K (-1.15 %) |
May 01 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 339 | 0 | 13,846 | 13.5 K to 13.8 K (+2.51 %) |
May 01 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 2,708 | |
May 01 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 38.50 | 159 | 6,122 | 2,237 | 2.4 K to 2.2 K (-6.64 %) |
May 01 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 2,396 | 2.1 K to 2.4 K (+16.48 %) |
May 01 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,250 | 0 | 10,000 | |
May 01 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Payment of Exercise | F | 38.50 | 584 | 22,484 | 6,422 | 7 K to 6.4 K (-8.34 %) |
May 01 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Buy | M | 0.00 | 1,250 | 0 | 7,006 | 5.8 K to 7 K (+21.72 %) |
May 01 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 271 | 0 | 2,166 | |
May 01 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 38.50 | 100 | 3,850 | 1,825 | 1.9 K to 1.8 K (-5.19 %) |
May 01 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 271 | 0 | 1,925 | 1.7 K to 1.9 K (+16.38 %) |
May 01 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 1,250 | 0 | 10,000 | |
May 01 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 38.50 | 459 | 17,672 | 25,180 | 25.6 K to 25.2 K (-1.79 %) |
May 01 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 1,250 | 0 | 25,639 | 24.4 K to 25.6 K (+5.13 %) |
May 01 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Option Exercise | M | 0.00 | 344 | 0 | 2,750 | |
May 01 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Payment of Exercise | F | 38.50 | 161 | 6,199 | 2,219 | 2.4 K to 2.2 K (-6.76 %) |
May 01 2012 | CPHD | CEPHEID | ARNOLD NICOLAAS | EVP, Worldwide Comm ... | Buy | M | 0.00 | 344 | 0 | 2,380 | 2 K to 2.4 K (+16.90 %) |
Apr 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | M | 0.00 | 1,250 | 0 | 3,750 | |
Apr 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | A | 35.72 | 48,750 | 1,741,350 | 48,750 | |
Apr 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 | |
Apr 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Payment of Exercise | F | 37.17 | 584 | 21,707 | 13,507 | 14.1 K to 13.5 K (-4.14 %) |
Apr 26 2012 | CPHD | CEPHEID | Reyes Humberto | Executive VP, COO | Buy | M | 0.00 | 1,250 | 0 | 14,091 | 12.8 K to 14.1 K (+9.73 %) |
Apr 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
Apr 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | A | 35.72 | 153,750 | 5,491,950 | 153,750 | |
Apr 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Option Exercise | A | 0.00 | 17,000 | 0 | 17,000 | |
Apr 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Payment of Exercise | F | 37.17 | 2,293 | 85,231 | 24,389 | 26.7 K to 24.4 K (-8.59 %) |
Apr 26 2012 | CPHD | CEPHEID | BISHOP JOHN L | CEO | Buy | M | 0.00 | 6,250 | 0 | 26,682 | 20.4 K to 26.7 K (+30.59 %) |
Apr 26 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Apr 26 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Payment of Exercise | F | 37.17 | 367 | 13,641 | 1,654 | 2 K to 1.7 K (-18.16 %) |
Apr 26 2012 | CPHD | CEPHEID | Enns Russell | Sr. VP, Regulatory | Buy | M | 0.00 | 1,000 | 0 | 2,021 | 1 K to 2 K (+97.94 %) |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 1,209 | 0 | 3,624 | |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 35.72 | 48,750 | 1,741,350 | 48,750 | |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 | |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 37.17 | 565 | 21,001 | 2,057 | 2.6 K to 2.1 K (-21.55 %) |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 1,209 | 0 | 2,622 | 1.4 K to 2.6 K (+85.56 %) |
Apr 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Apr 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | A | 35.72 | 48,750 | 1,741,350 | 48,750 | |
Apr 26 2012 | CPHD | CEPHEID | Miller Andrew | EVP, CFO | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 |